Gadi Peleg insider trades: Artemis Therapeutics (ATMS) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Gadi reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 18, 2018 | ATMS | ↓ Sell | 182 | $0.26 | $47 | Direct | Dec 19, 2018 (1d) |
| Mar 11, 2010 | INKS.OB | ↑ Buy | 3,200,000 | $0.13 | $400K | By NewCo Holdings Corp. | Mar 23, 2010 (12d) |
| Mar 11, 2010 | INKS.OB | ↑ Buy | 3,200,000 | $0.13 | $400K | By Peleg Investment Management LLC | Mar 23, 2010 (12d) |
| Mar 11, 2010 | INKS.OB | ↑ Buy | 1,600,000 | $0.13 | $200K | By Credit Agricole (Suisse) SA | Mar 23, 2010 (12d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Gadi Peleg's insider trades
Gadi Peleg is a director at Artemis Therapeutics (ATMS). Since Mar 11, 2010, Gadi has reported 3 open-market purchases worth $1.0M and 1 sale worth $47 on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ATMS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.